Since 2002, BioCrossroads has worked to catalyze innovation and collaboration within Indiana’s life sciences sector. The sector has grown at a remarkable pace and has generated billions of dollars in revenue for the state with $79 billion in economic impact in 2021. BioCrossroads plays a critical role by convening academic, philanthropic, and cross-sector employer partners, enhancing research development, and working to attract life sciences businesses, innovation, and talent to Indiana.  

This unique collaborative approach has proven to be successful in times of need. At the onset of the COVID-19 pandemic, BioCrossroads played a key role convening Indiana’s life science and healthcare partners troubleshoot COVID testing, vaccine development and deployment, and other needs for Indiana residents.  

The Richard M. Fairbanks Foundation has awarded $11.5 million to BioCrossroads since 2003 to advance the economic vitality of Indianapolis. 

Additional Posts

School Closure and Student Outcomes: What Does the Research Say?

Alex Cohen is the Director of Learning and Evaluation for the Richard M. Fairbanks Foundation. School closure is among the most controversial interventions in education, and the issue is back in the spotlight with Indianapolis Public Schools’ recent vote to close or transition four high schools. The impetus for the high school restructuring at IPS […]

Make 2017 the Year to Tackle Opioid Addiction

Indiana ranks among the worst states nationally when it comes to opioid use disorder – with drug overdoses in 2014 claiming more than 1,100 lives and costing the state $1.4 billion. But this year, we also may be one of the best positioned places to tackle the opioid epidemic by addressing its root causes and […]